The HMG-CoA Reductase Inhibitor Cerivastatin Lowers Advanced Glycation End Products in Patients with Type 2 Diabetes - Scharnagl, H; Stojakovic, T; Winkler, K; Rosinger, S; März, W; Boehm, B O (Experimental and Clinical Endocrinology & Diabetes, 2007)